Herpes zoster infection and statins: which implications in clinical practice?
- PMID: 30298219
- DOI: 10.1007/s10096-018-3399-z
Herpes zoster infection and statins: which implications in clinical practice?
Abstract
Herpes zoster (HZ), which is caused by reactivation of latent varicella zoster virus (VZV), constitutes a major public health concern in both short- and long-term periods. Over the last years, several epidemiological studies have demonstrated that statin use is associated with increased risk of HZ at cerebral level. Because statins are among the most popular and best-selling drugs in western countries, this potential negative pleiotropic effect could have important implications in the daily clinical practice. In the present manuscript, we reviewed the available data on the statin use and the relative risk of HZ infection.
Keywords: Herpes zoster; Immunomodulatory effect; Statin.
Comment in
-
Statin therapy and herpes virus reactivation-response to Zuin et al. paper.Eur J Clin Microbiol Infect Dis. 2019 Jun;38(6):1195-1197. doi: 10.1007/s10096-019-03513-2. Epub 2019 May 1. Eur J Clin Microbiol Infect Dis. 2019. PMID: 31044331 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
